These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 25818421

  • 1. A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts.
    Liu J, Dang L, Li D, Liang C, He X, Wu H, Qian A, Yang Z, Au DW, Chiang MW, Zhang BT, Han Q, Yue KK, Zhang H, Lv C, Pan X, Xu J, Bian Z, Shang P, Tan W, Liang Z, Guo B, Lu A, Zhang G.
    Biomaterials; 2015 Jun; 52():148-60. PubMed ID: 25818421
    [Abstract] [Full Text] [Related]

  • 2. Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.
    Liu J, Li D, Dang L, Liang C, Guo B, Lu C, He X, Cheung HY, He B, Liu B, Li F, Lu J, Wang L, Shaikh AB, Jiang F, Lu C, Peng S, Zhang Z, Zhang BT, Pan X, Xiao L, Lu A, Zhang G.
    Sci Rep; 2017 Jan 10; 7():40487. PubMed ID: 28071724
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-155 inhibition up-regulates LEPR to inhibit osteoclast activation and bone resorption via activation of AMPK in alendronate-treated osteoporotic mice.
    Mao Z, Zhu Y, Hao W, Chu C, Su H.
    IUBMB Life; 2019 Dec 10; 71(12):1916-1928. PubMed ID: 31317664
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-17/20a inhibits glucocorticoid-induced osteoclast differentiation and function through targeting RANKL expression in osteoblast cells.
    Shi C, Qi J, Huang P, Jiang M, Zhou Q, Zhou H, Kang H, Qian N, Yang Q, Guo L, Deng L.
    Bone; 2014 Nov 10; 68():67-75. PubMed ID: 25138550
    [Abstract] [Full Text] [Related]

  • 5. Suppression of Bone Resorption by miR-141 in Aged Rhesus Monkeys.
    Yang S, Zhang W, Cai M, Zhang Y, Jin F, Yan S, Baloch Z, Fang Z, Xue S, Tang R, Xiao J, Huang Q, Sun Y, Wang X.
    J Bone Miner Res; 2018 Oct 10; 33(10):1799-1812. PubMed ID: 29852535
    [Abstract] [Full Text] [Related]

  • 6. A bone-resorption surface-targeting nanoparticle to deliver anti-miR214 for osteoporosis therapy.
    Cai M, Yang L, Zhang S, Liu J, Sun Y, Wang X.
    Int J Nanomedicine; 2017 Oct 10; 12():7469-7482. PubMed ID: 29075114
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of miR-125b in Osteoblasts Improves Age-Related Changes in Bone Mass and Quality through Suppression of Osteoclast Formation.
    Ito S, Minamizaki T, Kohno S, Sotomaru Y, Kitaura Y, Ohba S, Sugiyama T, Aubin JE, Tanimoto K, Yoshiko Y.
    Int J Mol Sci; 2021 Jun 23; 22(13):. PubMed ID: 34201781
    [Abstract] [Full Text] [Related]

  • 8. MiR-126-5p regulates osteoclast differentiation and bone resorption in giant cell tumor through inhibition of MMP-13.
    Wu Z, Yin H, Liu T, Yan W, Li Z, Chen J, Chen H, Wang T, Jiang Z, Zhou W, Xiao J.
    Biochem Biophys Res Commun; 2014 Jan 17; 443(3):944-9. PubMed ID: 24360951
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regulation of osteoclast-mediated bone resorption by microRNA.
    Ji L, Li X, He S, Chen S.
    Cell Mol Life Sci; 2022 May 10; 79(6):287. PubMed ID: 35536437
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice.
    Kim HN, Lee JH, Jin WJ, Ko S, Jung K, Ha H, Lee ZH.
    Eur J Pharmacol; 2012 Sep 15; 691(1-3):69-76. PubMed ID: 22846626
    [Abstract] [Full Text] [Related]

  • 19. MiR-503 regulates osteoclastogenesis via targeting RANK.
    Chen C, Cheng P, Xie H, Zhou HD, Wu XP, Liao EY, Luo XH.
    J Bone Miner Res; 2014 Feb 15; 29(2):338-47. PubMed ID: 23821519
    [Abstract] [Full Text] [Related]

  • 20. Bilirubin increases viability and decreases osteoclast apoptosis contributing to osteoporosis in advanced liver diseases.
    Jurado S, Parés A, Peris P, Combalia A, Monegal A, Guañabens N.
    Bone; 2022 Sep 15; 162():116483. PubMed ID: 35787483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.